CRDL
Cardiol Therapeutics
$1.98
−$0.31 (−13.35%)Sep 10, 2026
Key metrics
The numbers that frame CRDL today
- Market cap
- $229.45M
- P/E (TTM)
- -9.4
- EV / FCF
- -12.2
- ROIC
- 1,321.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.88
- 52wk High
- $2.34
Growth
Revenue and earnings trend for CRDL
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CRDL
Is Cardiol Therapeutics a good buy?
Hold. Cardiol Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Cardiol Therapeutics is selling at a very high price.
What is the market capitalization of CRDL?
Cardiol Therapeutics's market capitalization is $229.45M.
What is the P/E ratio for CRDL stock?
Cardiol Therapeutics's current P/E ratio is -9.4.
What is the 52-week high for CRDL stock?
The 52-week high for Cardiol Therapeutics is $2.34. The current close of $1.98 is 15.4% below that high.
What is the 52-week low for CRDL stock?
The 52-week low for Cardiol Therapeutics is $0.88. The current close of $1.98 is 125% above that low.
Does CRDL stock pay dividends?
Cardiol Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CRDL?
Cardiol Therapeutics's Debt / Equity ratio is 0.